Geode Capital Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
|
|||||
|
2025
Q1 | $2.29M | Buy |
|
|||||
|
2024
Q4 | $4.97M | Buy |
|
|||||
|
2024
Q3 | $7.81M | Buy |
|
|||||
|
2024
Q2 | $6.29M | Buy |
|
|||||
|
2024
Q1 | $4.17M | Buy |
|
|||||
|
2023
Q4 | $2.73M | Buy |
|
|||||
|
2023
Q3 | $848K | Buy |
|
|||||
|
2023
Q2 | $1.21M | Sell |
|
|||||
|
2023
Q1 | $2.64M | Buy |
|
|||||
|
2022
Q4 | $4.7M | Buy |
|
|||||
|
2022
Q3 | $6.82M | Buy |
|
|||||
|
2022
Q2 | $5.44M | Buy |
|
|||||
|
2022
Q1 | $16.2M | Sell |
|
|||||
|
2021
Q4 | $22.1M | Buy |
|
|||||
|
2021
Q3 | $29.8M | Buy |
|
|||||
|
2021
Q2 | $17M | Buy |
|
|||||
|
2021
Q1 | $7.12M | Buy |
|
|||||
|
2020
Q4 | $6.27M | Buy |
|